Here is some good news for patients with chronic myeloid leukemia (CML): five years after starting imatinib mesylate (Gleevec, Novartis) therapy, nearly all patients in the International Randomized Study of Interferon and ST1571 (IRIS) were still responding to treatment. IRIS was designed to compare standard therapy (interferon alfa plus cytarabine) with imatinib in 1,106 patients [...]
Many heart patients who routinely receive stents to open arteries after angio-plasty might not be gaining any more permanent benefit than patients treated with drugs alone, according to a new controversial study. The researchers say that stents might be little better than the aggressive use of heart medications to prevent heart attacks and death and [...]
The new rotigotine transdermal system (Neupro, Schwarz Bioscience) is designed to treat symptoms of early Parkinson’s disease. A member of the dopamine agonist class of drugs, rotigo-tine is delivered continuously through the skin via a silicone-based patch that is replaced every 24 hours. acomplia online
